Market Place
Sourcing Support
J&J Files For FDA Approval Of DARZALEX FASPRO Regimen
30 Sep 2024 //
PR NEWSWIRE
Acquired approval for manufacturing and marketing generic drugs
15 Aug 2024 //
PRESS RELEASE
Biocon`s Generics Lenalidomide Receives Tentative Approval in US
02 Aug 2024 //
FDA
InnoCare`s Tafasitamab BLA Accepted For DLBCL Treatment In China
20 Jun 2024 //
BUSINESSWIRE
Enterome updates clinical data from ongoing EONHL1-20/SIDNEY trial EO2463
27 May 2024 //
PHARMABIZ
Dr Reddy`s healthy Q4 results fail to impress brokerages
08 May 2024 //
MONEYCONTROL
Bristol Myers to cut 6% of workforce, trim drug pipeline
25 Apr 2024 //
BIOPHARMADIVE
EC Approves Carvykti for RRMM| Int`l Myeloma Foundation
22 Apr 2024 //
PRESS RELEASE
IASO NMPA`s IND Approval for Equecabtagene Autoleucel for Treatment of Myeloma
29 Mar 2024 //
PR NEWSWIRE
Pfizer`s blood cancer therapy Adcetris succeeds in late-stage trial
13 Mar 2024 //
PRESS RELEASE
Qilu`s Generic Lenalidomide Receives Approval in the U.S.
22 Feb 2024 //
FDA
Starton Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Trial
04 Oct 2023 //
BUSINESSWIRE
Starton Announces the Opening of Site for STAR-LLD Lenalidomide Phase 1b Trial
13 Sep 2023 //
BUSINESSWIRE
Torrent`s Generic Lenalidomide Acetate Receives Approval in the U.S.
03 Aug 2023 //
FDA
With Revlimid sales down, BMS slashes 2023 revenue projection
27 Jul 2023 //
FIERCE PHARMA
Hetero`s Generic Lenalidomide Receives Receives Approval in the U.S.
11 May 2023 //
FDA
Biocon`s Generic Lenalidomide Receives Receives Approval in the U.S.
04 May 2023 //
FDA
Biocon Generic Lenalidomide Receives Approval in the U.S
04 May 2023 //
FDA
Natco Pharma launches additional strengths of generic version of Revlimid in US
10 Mar 2023 //
ECONOMIC TIMES
Teva and Natco Announce Launch of additional strengths for Revlimid
09 Mar 2023 //
BUSINESSWIRE
Arrow`s Generic Lenalidomide Receives Approval in the U.S.
06 Mar 2023 //
FDA
Zydus` Generic Lenalidomide Receives Approval in the U.S.
06 Mar 2023 //
FDA
Lotus` Generic Lenalidomide Receives Approval in the U.S.
06 Mar 2023 //
FDA
Sun`s Generic Lenalidomide Receives Approval in the U.S.
06 Mar 2023 //
FDA
Eugia`s Generic Lenalidomide Receives Approval in the U.S.
06 Mar 2023 //
FDA
Sun Pharma gets USFDA nod to market generic medication
10 Feb 2023 //
ECONOMIC TIMES
Bristol Myers turns attention to new products in wake of Revlimid patent loss
02 Feb 2023 //
ENDPTS
Claims against Dr Reddy`s over Revlimid in US dismissed
30 Dec 2022 //
ECONOMICTIMES
InnoCare Announces Approval of Tafasitamab in Combination With Lenalidomide
28 Dec 2022 //
BIOSPACE
China’s CDE grants approval for InnoCare’s NHL therapy trial
21 Dec 2022 //
CLINICALTRIALSARENA
InnoCare Announces Approval to Conduct a Ph II Clinical Trial of Orelabrutinib
20 Dec 2022 //
BUSINESSWIRE
Alfa Enriches API Supply by Adding Lenalidomide, Parecoxib & Rivaroxaban
20 Dec 2022 //
DIGITALJOURNAL
Mylan`s Generic Lenalidomide Receives Approval in the U.S.
14 Dec 2022 //
FDA
Janssen Presents Efficacy Analyses from MAIA Study Showing Results of DARZALEX
12 Dec 2022 //
PRNEWSWIRE
Starton Therapeutics’ STAR-LLD Continuous Delivery Shows Superior Reduction
12 Dec 2022 //
GLOBENEWSWIRE
Janssen Presents Data from MajesTEC-2 Trial of TECVAYLI with DARZALEX FASPRO
10 Dec 2022 //
PRNEWSWIRE
Dr Reddy`s sees generic Revlimid, other launches to keep US business firing
29 Oct 2022 //
HEALTHECONOMICTIMES
Bristol Myers counters Revlimid generics with 3 new launches
27 Oct 2022 //
FIERCEPHARMA
Pharma Readies For Price Caps On Glargine, Teneligliptin, Lenalidomide In India
20 Sep 2022 //
PINK SHEET
Zydus`s Generic Lenalidomide Receives Approval in the U.S.
12 Sep 2022 //
FDA
InnoCare Announces 1st Patient Dosed in PII Trial of Tafasitamab & Lenalidomide
08 Sep 2022 //
BUSINESSWIRE
Cipla gets US FDA nod for cancer drug
08 Sep 2022 //
EXPRESS PHARMA
Dr. Reddy`s Laboratories Announces the Launch of Lenalidomide Capsules in the U.S.
08 Sep 2022 //
BIOSPACE
Cipla receives USFDA approval for generic version of Revlimid
07 Sep 2022 //
BIZZBUZZ
Cipla receives USFDA approval for generic version of Revlimid
07 Sep 2022 //
PRNEWSWIRE
Mylan`s Generic Lenalidomide Receives Approval in the U.S.
30 Aug 2022 //
FDA
Apotex`s Generic Lenalidomide Receives Approval in the U.S.
30 Aug 2022 //
FDA
Dr. Reddy`s Generic Lenalidomide Receives Approval in the U.S.
30 Aug 2022 //
FDA
InnoCare`s BLA for Tafasitamab in Combination with Lenalidomide got Acceptence
30 Aug 2022 //
BUSINESSWIRE
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
29 Aug 2022 //
CLINICALTRIALSARENA
Dr Reddy`s gearing up to get substantial slice of Revlimid generic
03 Aug 2022 //
ECONOMIC TIMES
Starton Reports Positive Results from PI Study Evaluating STAR-LLD
13 Jul 2022 //
GLOBENEWSWIRE
BMS Settles Patent Dispute With Alembic Over Blockbuster Revlimid
11 Jul 2022 //
FDANEWS
Zydus Pivots To Multivariant COVID-19 Vaccine, Looks To Revlimid Opportunity
25 May 2022 //
THE SCRIP
With onset of generics, sales of BMS` Revlimid are fading fast
29 Apr 2022 //
FIERCEPHARMA
Teva launches Revlimid generic, the first to do so in U.S.
08 Mar 2022 //
FIERCEPHARMA
Sandoz launches generic Revlimid in 19 countries Europe,a competition for BMS`
23 Feb 2022 //
FIERCEPHARMA
Sandoz launches generic oncology treatment in Europe
19 Feb 2022 //
PMLIVE
Active Biotech Begins Dosing in comb. part of phase Ib/IIa study of tasquinimod
07 Feb 2022 //
GLOBENEWSWIRE
